Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811
Corinne M Doll, Jennifer Moughan, Alexander Klimowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial
In Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Neuro-Oncology
|
November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Paul W Sperduto, Penny Fang, Jing Li, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811
Corinne M Doll, Jennifer Moughan, Alexander Klimowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial
In Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Neuro-Oncology
|
November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Paul W Sperduto, Penny Fang, Jing Li, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
Page
of 5